MarianRewersMDPhD

Summary

• Marian Rewers, MD, PhD, professor of pediatrics and medicine, is the executive director of Barbara Davis Center for Diabetes at the University of Colorado. The Center serves >8000 children and adults with type 1 diabetes (T1D) and is the premier research institute in basic, translational, and clinical research into prevention, cure, and most effective treatment of T1D and its complications. Dr Rewers’ research into the etiology of T1D as well as insulin resistance and cardiovascular complications of both type 1 and 2 diabetes has generated more than 600 peer-reviewed publications. Dr. Rewers has led NIH-funded projects: the Diabetes Autoimmunity Study in the Young (DAISY), The Environmental Determinants of Diabetes in the Young (TEDDY), the Celiac Disease Autoimmunity Research (CEDAR), the Coronary Artery Calcification in Type 1 (CACTI) and Insulin Resistance Atherosclerosis Study (IRAS).These large prospective cohort studies have expanded our knowledge of the causes and risks of autoimmunity, T1D, and diabetic complications. To translate these results to public health and prevention, Dr. Rewers initiated the Autoimmunity Screening for Kids (ASK) supported by the Breakthrough T1D and Helmsley Charitable Trust. ASK has screened 35,000 general population children for presymptomatic T1D and celiac disease, monitored >1,000 children with autoimmunity to prevent complications of delayed diagnosis and provided access to prevention. Screen To Prevent (STOP) T1D - Dr Rewers’ recent program sponsored by Sanofi -offers healthcare providers structured education in screening and monitoring to lower the barriers to screening for early T1D across the U.S.